Niklas Landberg

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 8

Top Venues

Cancer discovery

Blood cancer discovery

European journal of haematology

Nature communications

Skåne University Hospital

Lund University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Skåne University Hospital Nov 01 2017

Sweden

Resident Physician in Hematology :: Department of Hematology and Oncology

Lund University Sep 01 2013 - Jan 24 2020

Sweden

PhD-student :: Department of Laboratory Medicine, Clinical Genetics

Skåne University Hospital Mar 01 2015 - Jun 30 2017

Sweden

Junior Doctor

Education History

Lund University Sep 01 2008 - Jan 15 2015

Sweden

MSC :: Faculty of Medicine

Publications

Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation. Blood cancer discovery (2024)
Niklas Landberg, Thomas Kohnke, Yang Feng, Yusuke Nakauchi, Amy C Fan, Miles H Linde, Daiki Karigane, Kelly Lim, Rahul Sinha, Luca Malcovati, Daniel Thomas, Ravindra Majeti
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation. Blood cancer discovery (2023)
Miles H Linde, Amy C Fan, Thomas Kohnke, Aaron C Trotman-Grant, Sarah F Gurev, Paul Phan, Feifei Zhao, Naomi L Haddock, Kevin A Nuno, Eric J Gars, Melissa Stafford, Payton L Marshall, Christopher G Dove, Ian L Linde, Niklas Landberg, Lindsay P Miller, Robbie G Majzner, Tian Yi Zhang, Ravindra Majeti
Reprogramming Cancer into Antigen Presenting Cells as a Novel Immunotherapy. Cancer discovery (2023)
Daniel Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A L Thompson-Peach, Kelly Lim, Niklas Landberg, Thomas Kohnke, Nirmal Robinson, Satinder Kaur, Monika M Kutyna, Melissa Stafford, Devendra K Hiwase, Andreas Reinisch, Gary Peltz, Ravindra Majeti
Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer discovery (2022)
Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martinez, Noelia Puente-Moncada, Carl Sandén, Anna M Blom, Rasmus Henningsson, Gunnar Juliusson, Ben C King, Niklas Landberg, Vladimir Lj Lazarevic, Christina Orsmark-Pietras, Marianne Rissler, Vendela Rissler, Helena Agerstam, Marcus Järås, Henrik Lilljebjörn, Thoas Fioretos
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML. Blood advances (2022)
Christina Orsmark-Pietras, Niklas Landberg, Fryderyk Lorenz, Bertil Uggla, Martin Höglund, Sören Lehmann, Åsa Derolf, Stefan Deneberg, Petar Antunovic, Jörg Cammenga, Lars Möllgård, Lovisa Wennström, Henrik Lilljebjorn, Marianne Rissler, Thoas Fioretos, Vladimir Lj Lazarevic
Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study. Genes, chromosomes & cancer 60 (6) (2021)
Carl Sandén, Henrik Lilljebjorn, Christina Orsmark Pietras, Rasmus Henningsson, Karim H Saba, Niklas Landberg, Hanna Thorsson, Sofia von Palffy, Pablo Peña-Martinez, Carl Högberg, Marianne Rissler, David Gisselsson, Vladimir Lj Lazarevic, Gunnar Juliusson, Helena Ågerstam, Thoas Fioretos
Clonal competition within complex evolutionary hierarchies shapes AML over time. Nature communications 11 (1) (2020)
Niklas Landberg, Arta Dreimane, Marianne Rissler, Rolf Billström, Helena Ågerstam
Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib. European journal of haematology 99 (5) (2017)

Niklas Landberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Niklas Landberg